DEVELOPMENT CREDIT FACILITY. Lilly shall make available to Amylin a credit facility in the aggregate principal amount of Sixty Million Dollars (U.S.$60,000,000.00) to assist Amylin in meeting its obligations with respect to Development of Products hereunder under the terms and conditions set forth in the Loan Agreement between the Parties of even date herewith.
Appears in 3 contracts
Sources: Collaboration Agreement, Collaboration Agreement, Collaboration Agreement (Amylin Pharmaceuticals Inc)